ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -1.6% | 31 | 0.0% | 0.00% | – |
| Q2 2023 | $63 | +1.6% | 31 | 0.0% | 0.00% | – |
| Q1 2023 | $62 | -59.5% | 31 | -52.3% | 0.00% | – |
| Q4 2022 | $153 | – | 65 | +109.7% | 0.00% | – |
| Q3 2022 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 31 | -46.6% | 0.00% | – |
| Q4 2021 | $0 | – | 58 | -44.8% | 0.00% | – |
| Q3 2021 | $0 | – | 105 | +238.7% | 0.00% | – |
| Q2 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 31 | -27.9% | 0.00% | – |
| Q2 2020 | $0 | – | 43 | +38.7% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 31 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 31 | -22.5% | 0.00% | – |
| Q2 2019 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 706,930 | $1,406,791 | 1.22% |
| Newtyn Management, LLC | 519,765 | $1,034,332 | 0.20% |
| Murchinson Ltd. | 52,800 | $100,680 | 0.01% |
| Marquette Asset Management, LLC | 17,318 | $34,463 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $93,427 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $64,597 | 0.00% |
| OSAIC HOLDINGS, INC. | 57 | $113 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 42,502 | $84,579 | 0.00% |
| Parallel Advisors, LLC | 244 | $486 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |